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Educating patients with atopic dermatitis (AD) is an 
essential and unavoidable component of therapy.[1] If the 
disease involves young children, education of parents is 
mandatory. Without adequate attention to education, 
all therapies are futile and the patient is doomed to an 
impaired quality of life. Practitioners treating patients with AD must be 
aware that the disease is one of the most important medical conditions 
that affects quality of life,[2] which usually involves the entire family.[3] 
While many of the educational principles centre on an adequate 
explanation of therapies and their appropriate application and 
timing, there are a number of factors that must be addressed, 
including:[4] 
• an explanation of the aetiology and pathology of the disease process
• avoidance of generic (cigarette smoke, irritants) and individual 
specific (allergens) trigger factors 
• attention to skin hygiene and care
• attention to itch prevention (adequate moisturisation, keeping 
nails short, and avoiding hot bedrooms, woollen clothing, over-
dressing and soaps)
• an explanation of the chronic and relapsing nature of the disease
• an explanation that all therapies can only treat, not cure, the 
condition
• an honest discussion about the side-effects of medication
• a discussion about the scientific basis of alternative therapies 
(homoeopathy, reflexology, naturopathy, acupuncture and herbal 
therapy). It should suggest that, while such therapies are not 
grounded by the same evidence required for allopathic medicine, 
many individuals feel compelled to try them when desperate. Such 
desperation can usually be overcome by careful attention to skin 
care and medicine use.
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Educating patients with atopic dermatitis is an essential and necessary part of therapy and particularly important when young children are 
involved. Quality of life is seriously impaired if patients or their carers do not understand the chronic and relapsing nature of the disease 
and how it can be treated.
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Table 1. Indications for referral to a specialist dermatological service
Immediate (same-day) referral
• If eczema herpeticum (KVE) is suspected* 
Urgent referral (within two weeks)
• If the AD is severe and has not responded to optimal topical therapy after one week  
• If treatment of bacterially infected AD has failed 
Routine (non-urgent) referral 
• The diagnosis is/has become uncertain
• AD on the face has not responded to appropriate treatment
• AD is associated with severe and recurrent infections
• Contact allergic dermatitis is suspected
• AD leads to serious social or psychological problems for the child, parent or carer
• The child, parent or carer might benefit from specialist advice regarding treatment 
• AD has not been controlled satisfactorily according to a subjective assessment by the child, parent or carer
AD = atopic dermatitis.
*KVE = Kaposi’s varicelliform eruption. KVE refers to viral (herpes simplex virus/eczema herpeticum, vaccinia virus/eczema vaccinatum, and Coxsackie virus/eczema coxsackium) infection 
superimposed on AD. Eczema herpeticum is the most common.
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Educational messages need to be repeated frequently. Patients and 
parents must be given adequate opportunity to raise concerns and ask 
questions. AD consultations, even follow-up visits, are usually quite 
long. Education is greatly aided by providing information leaflets, 
reputable website addresses and contact details for support groups.[5] 
The majority of patients with AD respond to dedicated conservative 
treatment. Indications for referral to a specialist are listed in Table 1.
There are also additional indications. Patients, parents or caregivers 
with corticosteroid phobia (CSP) should be referred, because it 
occurs frequently and is not an irrational fear. It describes all types of 
fear about steroid use. In routine clinical practice, it is not unusual for 
patients to express fear or anxiety about using topical corticosteroids. 
Topical CSP, a complex phenomenon, may lead to poor adherence 
and lack of response. 
All patients presenting with erythroderma (dermatitis involving >90% 
of body surface area), any acute flare (spontaneous or precipitated by 
irritation of the skin), infection, stress or inadequate itch control 
need referral.
References
1. Kupfer J, Gieler U, Diepgen TL, et al. Structured education program improves the coping with atopic 
dermatitis in children and their parents – a multicenter, randomized controlled trial. J Psychosom Res 
2010;68(4):353-358. [http://dx.doi.org/10.1016/j.jpsychores.2009.04.014]
2. Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic 
eczema. Br J Dermatol 2006;154:719-725. [http://dx.doi.org/10.1111/j.1365-2133.2005.07050.x]
3. Moore EJ, Williams A, Manias E, Varigos G, Donath S. Eczema workshops reduce severity of 
childhood atopic eczema. Australas J Dermatol 2009;50(2):100-106. [http://dx.doi.org/10.1111/j.1440-
0960.2009.00515.x]
4. Ogawa S, Uchi H, Fukagawa S. Development of atopic dermatitis-specific communication tools: Interview form and 
question and answer brochure. J Dermatol 2007;34(3):164-171. [http://dx.doi.org/10.1111/j.1346-8138.2007.00243.x]
5. Chisolm SS, Taylor SL, Balkrishnan R, Feldman SR. Written action plans: Potential for improving 
outcomes in children with atopic dermatitis. J Am Acad Dermatol 2008;59(4):677-683. [http://dx.doi.
org/10.1016/j.jaad.2008.04.025]
